Washington Research Foundation (WRF) has awarded $6 million in grant funding through a new program designed to support late-stage preclinical development and first-in-human clinical trials of novel ...

While there have been exciting advancements in the treatment of B-cell acute lymphoblastic leukemia over the course of the past decade, the treatment of older adults remains a challenge.

A research team, affiliated with UNIST has developed nanoparticles that effectively treat acute myeloid leukemia (AML), ...

The once-powerful producer convicted of rape has been diagnosed with a type of bone marrow cancer, according to multiple ...

PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP), a clinical-stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today ...

AvenCell Therapeutics on Tuesday said it collected $112 million to continue clinical studies of two experimental acute ...

AvenCell Therapeutics has secured $112 million in series B funds as the Novo Holdings-backed biotech seeks clinical proof ...

More than 400 people, 80% of them being children under 14 years old, will be diagnosed with B-cell Acute Lymphoblastic ...

Immunotherapy and precision medicine show promise in better fighting cancer. What else does the research tell us?

A 6 year old arkansan battling leukemia was recognized at the 6th annual lift againt leukemia today.T-cell acute ...